Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Inanovate
AddedFeb 15, 2024
UpdatedJun 18, 2026
Inanovate

Inanovate

Closed

Inanovate, a US-based company founded by Babson MBA grads, pioneers in business innovation.

HQ
Sioux Falls, SD, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Inanovate, founded by Babson MBA graduates in Massachusetts, focuses on revolutionizing diagnostic testing. Their core mission is to enhance the accuracy and affordability of disease diagnostics. The company’s flagship product, Bio-ID, is a compact bench-top analyzer paired with disposable test cartridges that measure multiple biomarkers from blood samples, aiming to improve diagnostic precision and reduce costs. Inanovate targets healthcare providers and laboratories seeking efficient diagnostic solutions.

Notable figures associated with Inanovate include its founding team of Babson MBA graduates. The company has achieved significant milestones, such as completing testing and benchmarking for Bio-ID, which underscores its technological advancements. By lowering diagnostic costs and improving accuracy, Inanovate has made a substantial impact on the healthcare industry, driving innovation in disease detection and patient care.

Inanovate - Similar Companies

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Innovative Biosensors logo

Innovative Biosensors

In Diagnostics logo

In Diagnostics

indiagnostics.com

InnSight Technology logo

InnSight Technology

innsightech.com

BioAnalytics logo

BioAnalytics

Instadiagnostics logo

Instadiagnostics

Evanostics logo

Evanostics

Empowered Diagnostics logo

Empowered Diagnostics

Banyan Biomarkers logo

Banyan Biomarkers

FBB Biomed logo

FBB Biomed

fbbbio.com

Innovaprep logo

Innovaprep

innovaprep.com

INanoBio logo

INanoBio

inanobio.com

Ainnova Tech logo

Ainnova Tech

ainnovatech.com

Eido Innova logo

Eido Innova

Inflammatix logo

Inflammatix

inflammatix.com

Inanovate - Quick Facts

Who are Inanovate's competitors?

Companies similar to Inanovate include Babson Diagnostics, Innovative Biosensors, In Diagnostics and InnSight Technology.

When was Inanovate founded?

Inanovate was founded in 2006.

Where is Inanovate's headquarters located?

Inanovate's headquarters is located in Sioux Falls, SD, US.

When was Inanovate's last funding round?

Inanovate's most recent funding round was for $1.5M (USD) in December 2023.

How much has Inanovate raised to-date?

As of Dec 11, 2023, Inanovate has raised a total of $9.6M (USD).

Inanovate - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Tests
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified